| abstract |
The present invention discloses novel derivatives of isoflavones, in particular carboxy derivatives of isoflavones, active as selective estrogen receptor modulators, and uses of the carboxy derivatives for the treatment of estrogen-related conditions. The present further discloses conjugates of said carboxy derivatives of isoflavones and their use for affinity targeting of drugs, imaging and detection agents to cells having estrogen receptors, particularly estrogen receptors subtype β. |